ABP
Abpro Corporation
1W: +20.0%
1M: -85.5%
3M: -98.0%
YTD: -97.2%
1Y: -99.2%
$0.52
Last traded 2026-03-16 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.1M
52W Range0.11-18.03
Volume1,332,443
Avg Volume1,719,761
Beta-0.00
Dividend—
Analyst Ratings
Company Info
CEOJin Wook Suk
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2022-03-09
Websiteabpro.com
68 Cummings Park Drive
Woburn, MA 01801
US
Woburn, MA 01801
US
617 225 0808
About Abpro Corporation
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
Latest News
Short Interest in Abpro Holdings Inc. (NASDAQ:ABP) Increases By 271.4%
Abpro's Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72
Abpro (NASDAQ:ABP) Stock Price Up 0.2% – Still a Buy?
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Suk Jin Wook (Miles) | P-Purchase | 72,035 | $0.28 | 2025-07-31 |
| Lee Soo Young | A-Award | 60,600 | $0.32 | 2025-07-25 |
| Eisenberg Anthony D. | A-Award | 60,600 | $0.32 | 2025-07-25 |
| Suk Jin Wook (Miles) | A-Award | 500,000 | — | 2025-07-25 |
| Suk Jin Wook (Miles) | P-Purchase | 16,200 | $0.26 | 2025-05-19 |